Chronic hepatitis B, liver cancer
Conditions
Interventions
research group:non-intervention
Sponsors
Peking University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with chronic hepatitis B who meet all of the following criteria are admitted to this study: (1) Age 18 or above, male or female; (2) HBsAg and/or HBV DNA positive for more than 6 months; (3) Voluntary participation in this study, able to understand and sign informed consent.
Exclusion criteria
Exclusion criteria: Subjects with any of the following conditions will not participate in the study: (1) Prior to participating in this study, HIV and other viral infections have been confirmed; (2) Patients with a history of transplantation of major functional organs; (3) The subject has a history of clinically and lab-proven pancreatitis, or has developed clinical or laboratory manifestations related to current pancreatitis; (4) Unable to understand or unwilling to sign the informed consent, or failing to comply with the study provisions; (5) Other conditions deemed unsuitable for inclusion by the researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| AFP;PIVKA-II; | — |
Secondary
| Measure | Time frame |
|---|---|
| Ferritin; | — |
Countries
China
Contacts
Public ContactLu Fengmin
Peking University
Outcome results
None listed